GASTRIC PH CONTROL IN CRITICALLY ILL CHILDREN RECEIVING INTRAVENOUS RANITIDINE

Citation
Am. Harrison et al., GASTRIC PH CONTROL IN CRITICALLY ILL CHILDREN RECEIVING INTRAVENOUS RANITIDINE, Critical care medicine, 26(8), 1998, pp. 1433-1436
Citations number
24
Categorie Soggetti
Emergency Medicine & Critical Care
Journal title
ISSN journal
00903493
Volume
26
Issue
8
Year of publication
1998
Pages
1433 - 1436
Database
ISI
SICI code
0090-3493(1998)26:8<1433:GPCICI>2.0.ZU;2-3
Abstract
Objective: To determine whether the dose of ranitidine recommended in commonly used pediatric drug dosage handbooks (2 to 4 mg/kg/day iv) re sults in successful gastric pH control (pH of greater than or equal to 4) in critically ill children, Design: Prospective sample. Setting: P ediatric intensive care unit in a tertiary care children's hospital,Pa tients: Fifty consecutive patients who received greater than or equal to 24 hrs of scheduled intermittent intravenous ranitidine for stress ulcer prophylaxis were enrolled in the study. Patients with renal or h epatic dysfunction and those who received enteral nutrition through th e nasogastric tube were excluded from enrollment. Intervention: Gastri c pH was determined at the end of the ranitidine dosing interval, 1 hr after the dose, and at the midpoint between doses. Alt pH measurement s were made from a sample of nasogastric aspirate, using pH sensitive paper. Gastric pH control with ranitidine was considered unsuccessful (poorly controlled) if the pH was <4 for any of the three measurements , Measurements and Main Results: Forty five patients (median age 36 mo s; range 2 wks to 264 mos) were included in the analysis, Eighty-two p ercent of the patients were mechanically ventilated, 16% were pharmaco logically paralyzed, 18% required vasoactive infusions, 36% were nouri shed via transpyloric feeding tubes, and 7% received total parenteral nutrition. Gastric pH was poorly controlled in 36% of patients. Among these patients, the pH at the end of the dosing interval was significa ntly lower than the pH measured at 1 hr or at the midpoint between dos es (p < .05). Seventy-one percent of patients who received <3 mg/kg/da y of ranitidine had poor gastric pH control as compared with 19% who r eceived a minimum of 3 mg/kg/day (p < .05). Poor control of gastric pH was not associated with feeding, intubation status, presence of pharm acologic paralysis, use of vasoactive infusions, or age (p > .05). Con clusions: The minimum ranitidine dose recommended in commonly used ped iatric drug references resulted in unsuccessful gastric pH control in a high percentage of pediatric intensive care unit patients. Criticall y ill children with normal renal and hepatic function should be treate d with a minimum 3 mg/kg/day of intravenous ranitidine and the dose sh ould be titrated to a gastric pH of greater than or equal to 4.